Selecting a reliable biochemistry exploration Chonluten supplier requires strict verification of peptide purity, structural identity, and batch-to-batch consistency. PX1 Research provides laboratory-grade Chonluten (Glu-Asp-Gly) synthesized under rigid quality standards, supported by comprehensive third-party RP-HPLC and ESI-MS certificates of analysis for advanced in vitro and preclinical research applications.
Selecting a reliable biochemistry exploration Chonluten supplier requires strict verification of peptide purity, structural identity, and batch-to-batch consistency. PX1 Research provides laboratory-grade Chonluten (Glu-Asp-Gly) synthesized under rigid quality standards, supported by comprehensive third-party RP-HPLC and ESI-MS certificates of analysis for advanced in vitro and preclinical research applications.
A qualified biochemistry exploration Chonluten supplier must meet stringent criteria to support rigorous academic and industrial research. Chonluten is a short synthetic bioregulatory tripeptide composed of L-glutamic acid, L-aspartic acid, and glycine (H-Glu-Asp-Gly-OH). Because minor impurities, peptide fragments, or residual organic solvents can alter cellular assays and mask mechanistic observations, research laboratories require raw materials verified by definitive analytical methods.
When sourcing research compounds for laboratory exploration, investigators must prioritize transparency, analytical verification, and manufacturing compliance. PX1 Research serves as a trusted domestic supplier, providing researchers with fully characterized Chonluten 10mg peptide vials accompanied by lot-specific documentation. Every lot undergoes rigorous testing to guarantee sequence fidelity and freedom from residual bacterial endotoxins, enabling reproducible findings across cellular and molecular studies.
Chonluten belongs to the class of short bioregulatory peptides initially identified during research into organ-specific peptide complexes. Chemically defined as L-α-glutamyl-L-α-aspartyl-glycine (EDG), the compound has a low molecular weight of approximately 305.24 g/mol. Its primary structure consists of two acidic amino acid residues coupled to a terminal glycine, creating a distinct spatial charge distribution at physiological pH.
The small molecular footprint of Chonluten allows it to interact directly with the major and minor grooves of double-stranded DNA in nuclear assays. Preclinical investigations into bioregulatory peptide mechanisms indicate that tripeptides like EDG can penetrate cellular and nuclear membranes without requiring specialized transporter systems. This structural characteristic makes Chonluten a target for studies evaluating non-covalent peptide-DNA binding, histone interactions, and direct epigenetic modulation in cell-free systems.
Preclinical studies evaluating Chonluten have focused heavily on respiratory epithelial cell lines, chromatin structure, and gene expression profiles under stress conditions. In vitro data indicate that exposure to Chonluten induces localized chromatin decondensation in cultured human fibroblasts and bronchial epithelial cells. This structural rearrangement of nuclear chromatin is associated with enhanced transcriptional availability of specific genomic regions.
In cell culture models of oxidative stress and inflammatory challenge, Chonluten administration has been observed to modulate the expression of genes encoding antioxidant enzymes, such as superoxide dismutase (SOD) and glutathione peroxidase. Furthermore, rodent models of lipopolysaccharide (LPS)-induced acute lung injury demonstrate that treatment with synthetic EDG reduces the local accumulation of pro-inflammatory cytokines, including TNF-α and IL-6, within bronchoalveolar lavage fluid. These findings suggest that the peptide may act as an epigenetic signaling molecule capable of stabilizing epithelial barrier integrity during environmental or oxidative insult.
To contextualize Chonluten within modern peptide research, investigators frequently compare its activity against other short synthetic sequences targeting distinct organ systems. For example, while Chonluten (Glu-Asp-Gly) is predominantly evaluated in bronchial and epithelial models, compounds such as Bronchogen (Ala-Glu-Asp-Leu) share an overlapping focus on lung biochemistry but exhibit distinct structural kinetics due to the inclusion of hydrophobic alanine and leucine residues.
Similarly, research involving the short pineal-derived peptide Epitalon (Ala-Glu-Asp-Gly) highlights how a single amino acid substitution at the N-terminus alters sequence specificity, turning an epithelial-targeted tripeptide into a tetrapeptide heavily studied for telomerase activity and circadian rhythm gene expression. Another related compound, Thymogen (Glu-Trp), demonstrates immunomodulatory signaling through T-cell differentiation pathways. Comparing these compounds within a standardized assay matrix allows research teams to map how minor sequence modifications dictate tissue-specific binding affinities and downstream signaling cascades across our catalog of high-purity research peptides.
A primary concern when choosing a biochemistry exploration Chonluten supplier is confirming the physical chemical identity of the supplied material. Mass spectrometry and chromatographic profiling are non-negotiable standards for laboratory-grade reagents. High-Performance Liquid Chromatography (RP-HPLC) using C18 reverse-phase columns is employed to establish chemical purity, ensuring that the target peptide peak accounts for ≥98% of total integrated UV absorbance.
Simultaneously, Electrospray Ionization Mass Spectrometry (ESI-MS) confirms the exact molecular mass of the H-Glu-Asp-Gly-OH sequence, ruling out truncated sequences, deletion peptides, or residual protecting groups from solid-phase synthesis. Furthermore, because Chonluten is frequently studied in cell culture assays sensitive to bacterial pyrogens, PX1 Research subjects every batch to Limulus Amebocyte Lysate (LAL) testing. Ensuring endotoxin levels remain below 0.1 EU/mg prevents false-positive inflammatory responses in sensitive cell lines, a critical detail outlined in our HPLC and Mass Spectrometry validation standards.
Proper handling and solution preparation are vital to maintaining the structural integrity of Chonluten during experimental workflows. Lyophilized Chonluten is supplied as a sterile, white powder that exhibits high solubility in aqueous buffer systems. For standard biochemical assays, researchers typically follow established reconstitution guidelines for laboratory peptides, dissolving the solid matrix in sterile bacteriostatic water or phosphate-buffered saline (PBS, pH 7.4).
Because Chonluten contains two acidic amino acid residues (Glu and Asp), extreme alkaline conditions should be avoided to prevent deamidation or peptide bond hydrolysis over prolonged storage. Once reconstituted, stock solutions should be aliquoted into sterile polypropylene microcentrifuge tubes to avoid repeated freeze-thaw cycles. Lyophilized vials remain stable at -20°C for up to 24 months, whereas reconstituted liquid aliquots should be maintained at -80°C for long-term storage or 4°C for short-term experimentation (under 7 days).
Sourcing research peptides from unverified overseas suppliers introduces significant risks, including batch-to-batch variability, missing analytical documentation, solvent contamination, and delayed shipping timelines that compromise cold-chain storage. PX1 Research operates as a dedicated domestic supplier, manufacturing and packaging peptides in state-of-the-art facilities compliant with Good Manufacturing Practices (GMP) and supported by ISO 17025 accredited testing laboratories.
By maintaining operations within California and Arizona, PX1 Research guarantees fast, same-day domestic dispatch for orders placed before daily cutoffs. Laboratories establishing bulk research peptide accounts receive direct access to lot-specific Certificate of Analysis (COA) documents, raw MS spectra, and chromatograms. This level of supply chain security ensures that experimental data generated using PX1 compounds remains reproducible, traceable, and publishable in peer-reviewed journals.
As the scientific community continues to explore non-coding genomic regulation and peptide-mediated gene expression, short synthetic peptides like Chonluten represent valuable molecular tools. Current research trajectories include investigating how EDG influences chromatin accessibility via microscale thermophoresis (MST) and chromatin immunoprecipitation (ChIP) sequencing assays. Understanding these structural interactions provides crucial insights into basic cell biology and gene regulation mechanisms.
By supplying high-purity, fully documented research compounds, PX1 Research remains committed to advancing basic biochemical research. Whether conducting high-throughput cell viability assays, studying protein expression profiles in respiratory tissue models, or mapping epigenetic modifications, choosing a rigorous supplier ensures your laboratory builds its findings on a foundation of absolute chemical purity and consistency.
What is Chonluten (EDG) and what is its molecular composition?
Chonluten is a synthetic bioregulatory tripeptide consisting of L-glutamic acid, L-aspartic acid, and glycine (sequence: H-Glu-Asp-Gly-OH). It has a molecular weight of 305.24 g/mol and is supplied as a pure lyophilized powder for laboratory research use.
What analytical testing is performed on PX1 Research Chonluten?
Every lot of Chonluten undergoes Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) for purity determination (≥98%), Electrospray Ionization Mass Spectrometry (ESI-MS) for sequence mass verification, and LAL assay testing to confirm endotoxin levels are below 0.1 EU/mg.
Is Chonluten approved for human consumption or therapeutic use?
No. Chonluten supplied by PX1 Research is strictly designated for laboratory research, in vitro assays, and preclinical animal models. It is not intended for human or veterinary use, medical treatment, or clinical administration.
How should lyophilized Chonluten be stored upon delivery?
Desiccated lyophilized Chonluten should be stored at -20°C for long-term stability (up to 24 months). Protect the vial from light and moisture exposure prior to reconstitution.
What solvent is recommended for reconstituting Chonluten for in vitro research?
Chonluten easily dissolves in sterile bacteriostatic water, sterile water for injection, or standard phosphate-buffered saline (PBS, pH 7.4). Gentle agitation is recommended; avoid vigorous vortexing.
How does Chonluten differ structurally from Bronchogen?
Chonluten is a tripeptide (Glu-Asp-Gly), whereas Bronchogen is a tetrapeptide (Ala-Glu-Asp-Leu). While both are studied in respiratory epithelial models, their differing amino acid compositions yield unique physicochemical properties and binding characteristics in cell assays.
Can I obtain a lot-specific Certificate of Analysis (COA) for my order?
Yes. PX1 Research provides publicly accessible, lot-specific COAs for every peptide sold. The COA includes raw HPLC chromatograms, mass spectrum plots, and endotoxin assay results.
Where does PX1 Research ship Chonluten from?
All PX1 Research peptides are manufactured, stored, and shipped directly from our domestic facilities located in California and Arizona, ensuring rapid delivery and eliminating customs delays.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.